Challenges in the pharmaceutical development of lipid-based short interfering ribonucleic acid therapeutics

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Expert Opinion on Drug Delivery

• Publication date

  2012-01-18

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1517/17425247.2012.642363PMID 22251440
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RNA interference in the clinic: challenges and future directions

  2011cited by this paper
• Cellular delivery of siRNA and antisense oligonucleotides via receptor-mediated endocytosis

  2011cited by this paper
• Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems

  2011cited by this paper
• Unconventional internalization mechanisms underlying functional delivery of antisense oligonucleotides via cationic lipoplexes and polyplexes.

  2011cited by this paper
• Medicinal chemistry of siRNA delivery.

  2010cited by this paper
• Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms.

  2010cited by this paper
• The role of liver sinusoidal cells in hepatocyte-directed gene transfer.

  2010cited by this paper
• Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms.

  2010cited by this paper
• A Novel Mechanism Is Involved in Cationic Lipid-Mediated Functional siRNA Delivery

  2009cited by this paper
• siRNA conjugate delivery systems.

  2009cited by this paper
• Biological barriers to therapy with antisense and siRNA oligonucleotides.

  2009cited by this paper
• Knocking down barriers: advances in siRNA delivery

  2009cited by this paper
• Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy

  2009cited by this paper
• Development of a Novel Method for Formulating Stable siRNA-Loaded Lipid Particles for In vivo Use

  2009cited by this paper
• Composite block copolymer stabilized nanoparticles: simultaneous encapsulation of organic actives and inorganic nanostructures.

  2008cited by this paper
• Subcellular compartment targeting of layered double hydroxide nanoparticles.

  2008cited by this paper
• The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer

  2008cited by this paper
• Liposomal nanomedicines

  2008cited by this paper
• Species differences in transgene DNA uptake in hepatocytes after adenoviral transfer correlate with the size of endothelial fenestrae

  2007cited by this paper
• Sheddable Coatings for Long-Circulating Nanoparticles

  2007cited by this paper
• Interfering with disease: a progress report on siRNA-based therapeutics

  2007cited by this paper
• Targeted quantum dot conjugates for siRNA delivery.

  2007cited by this paper
• Recent Advances in Lipid Oxidation

  2007cited by this paper
• Targeted delivery systems of small interfering RNA by systemic administration.

  2007cited by this paper
• Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes

  2007cited by this paper
• RNAi-mediated gene silencing in non-human primates

  2006cited by this paper
• Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection.

  2006cited by this paper
• Fluid mixing in a T-shaped micro-mixer

  2006cited by this paper
• Disassembly and reassembly of yeast-derived recombinant human papillomavirus virus-like particles (HPV VLPs).

  2006cited by this paper
• Micromixers—a review

  2005cited by this paper
• The silent revolution: RNA interference as basic biology, research tool, and therapeutic.

  2005cited by this paper
• Peroxide-mediated desulfurization of phosphorothioate oligonucleotides and its prevention.

  2005cited by this paper
• A Scalable, Extrusion-Free Method for Efficient Liposomal Encapsulation of Plasmid DNA

  2005cited by this paper
• Stabilized plasmid-lipid particles containing PEG-diacylglycerols exhibit extended circulation lifetimes and tumor selective gene expression.

  2005cited by this paper
• Interaction with Blood Components Plays a Crucial Role in Asialoglycoprotein Receptor-Mediated in Vivo Gene Transfer by Galactosylated Lipoplex

  2005cited by this paper
• The size of sinusoidal fenestrae is a critical determinant of hepatocyte transduction after adenoviral gene transfer

  2004cited by this paper
• DOTAP (and other cationic lipids): chemistry, biophysics, and transfection.

  2004cited by this paper
• Self-assembling nucleic acid delivery vehicles via linear, water-soluble, cyclodextrin-containing polymers.

  2004cited by this paper
• Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs

  2004cited by this paper
• In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: effects of PEG chain length and PC incorporation.

  2004cited by this paper
• Flash NanoPrecipitation of Organic Actives and Block Copolymers using a Confined Impinging Jets Mixer

  2003cited by this paper
• Pharmacokinetics of liposomes designed to carry glucocorticoids.

  2003cited by this paper
• Cationic lipid vectors for plasmid DNA delivery.

  2003cited by this paper
• Measurement of Crystal Growth and Nucleation Rates

  2002cited by this paper
• Phase behavior of cationic amphiphiles and their mixtures with helper lipid influences lipoplex shape, DNA translocation, and transfection efficiency.

  2002cited by this paper
• Rapid microfluidic mixing.

  2002cited by this paper
• Oxidative degradation of pharmaceuticals: theory, mechanisms and inhibition.

  2001cited by this paper
• Spherical Micelles and Other Self-Assembled Structures in Dilute Aqueous Mixtures of Poly(Ethylene Glycol) Lipids

  2001cited by this paper
• Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures.

  2001cited by this paper
• Roles of lipid polymorphism in intracellular delivery.

  2001cited by this paper
• Phase Behavior, DNA Ordering, and Size Instability of Cationic Lipoplexes

  2001cited by this paper
• Spontaneous entrapment of polynucleotides upon electrostatic interaction with ethanol-destabilized cationic liposomes.

  2001cited by this paper
• On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids

  2001cited by this paper
• A novel, long-circulating, and functional liposomal formulation of antisense oligodeoxynucleotides targeted against MDR1

  2000cited by this paper
• Damage to liposomal lipids: protection by antioxidants and cholesterol-mediated dehydration.

  2000cited by this paper
• Stabilized plasmid-lipid particles: construction and characterization

  1999cited by this paper
• Comparison of different hydrophobic anchors conjugated to poly(ethylene glycol): effects on the pharmacokinetics of liposomal vincristine.

  1998cited by this paper
• Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

  1998cited by this paper
• Effect of chain density on inhibition of protein adsorption by poly(ethylene glycol) based coatings

  1998cited by this paper
• An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery.

  1998cited by this paper
• Structure of DNA-Cationic Liposome Complexes: DNA Intercalation in Multilamellar Membranes in Distinct Interhelical Packing Regimes

  1997cited by this paper
• The “Stealth” Liposome: A Prototypical Biomaterial

  1996cited by this paper
• Poly(ethylene glycol)--lipid conjugates regulate the calcium-induced fusion of liposomes composed of phosphatidylethanolamine and phosphatidylserine.

  1996cited by this paper
• The role of helper lipids in cationic liposome-mediated gene transfer.

  1996cited by this paper
• Structure and Function of Sinusoidal Lining Cells in the Liver

  1996cited by this paper
• Micromixing effects in a two-impinging-jets precipitator

  1996cited by this paper
• Ostwald ripening in emulsions

  1995cited by this paper
• Chemical hydrolysis of phospholipids.

  1995cited by this paper
• Abrupt modifications of phospholipid bilayer properties at critical cholesterol concentrations.

  1995cited by this paper
• Physical stability of different liposome compositions obtained by extrusion method.

  1995cited by this paper
• Liposomes as Carriers for Drugs and Antigens: Approaches to Preserve Their Long Term Stability

  1994cited by this paper
• The effect of surface charge on the hydrolysis kinetics of partially hydrogenated egg phosphatidylcholine and egg phosphatidylglycerol in aqueous liposome dispersions.

  1993cited by this paper
• Chemical stability of liposomes: implications for their physical stability.

  1993cited by this paper
• Stabilization of liposomes by freeze-thaw- and lyophilization techniques : problems and opportunities

  1992cited by this paper
• The effect of aging on the physical stability of liposome dispersions.

  1992cited by this paper
• Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles.

  1991cited by this paper
• Review. Recent advances in lipid oxidation

  1991cited by this paper
• Experimental evidence for and prediction of micromixing effects in precipitation

  1991cited by this paper
• Hydrolysis of phosphatidylcholine in aqueous liposome dispersions

  1989cited by this paper
• The kinetics of the autoxidation of polyunsaturated fatty acids

  1987cited by this paper
• Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.

  1987cited by this paper
• Influence of lipid composition and ionic strength on the physical stability of liposomes.

  1984cited by this paper
• Amine autoxidation in aqueous solution

  1983cited by this paper
• Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro.

  1980cited by this paper
• Entrapment of plasmid DNA by liposomes and their interactions with plant protoplasts.

  1979cited by this paper

• 20 years of flash nanoprecipitation - from controlled precipitation to global medicine.

  2025cites this paper
• Molecular Insight into Lipid Nanoparticle Assembly from NMR Spectroscopy and Molecular Dynamics Simulation.

  2025cites this paper
• Role of noncoding RNA as a pacemaker in cancer stem cell regulation: a review article

  2025cites this paper
• Toward the Scalable, Rapid, Reproducible, and Cost-Effective Synthesis of Personalized Nanomedicines at the Point of Care.

  2024cites this paper
• Design of lipid-based nanoparticles for delivery of therapeutic nucleic acids.

  2023cites this paper
• Delivery of siRNA using cationic rosette nanotubes for gene silencing.

  2023cites this paper
• Small Interfering RNA for Gliomas Treatment: Overcoming Hurdles in Delivery

  2022cites this paper
• Perspectives of using microRNA-loaded nanocarriers for epigenetic reprogramming of drug resistant colorectal cancers.

  2022cites this paper
• Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugs

  2021cites this paper
• Paclitaxel loading in cationic liposome vectors is enhanced by replacement of oleoyl with linoleoyl tails with distinct lipid shapes

  2021cites this paper
• Cationic Liposomes as Vectors for Nucleic Acid and Hydrophobic Drug Therapeutics

  2021cites this paper
• RNA-based therapeutics in cardiovascular disease.

  2020cites this paper
• Enhanced Loading of Paclitaxel in Cationic Liposomes by Replacement of Oleoyl with Linoleoyl Lipid Tails with Benefits in Cancer Therapeutics from In Vitro Studies

  2020cites this paper
• A 3D columnar phase of stacked short DNA organized by coherent membrane undulations.

  2019cites this paper
• Lipid Nanoparticles for Delivery of Therapeutic RNA Oligonucleotides.

  2019cites this paper
• R

  2019cites this paper
• Next-Generation Lipids in RNA Interference Therapeutics.

  2017cites this paper
• Mathematical Modeling: A Tool for Optimization of Lipid Nanoparticle-Mediated Delivery of siRNA

  2017cites this paper
• In vitro 3D model and miRNA drug delivery to target calcific aortic valve disease.

  2017cites this paper
• Non-coding RNAs: Therapeutic Strategies and Delivery Systems.

  2016cites this paper
• Cationic liposome–nucleic acid nanoparticle assemblies with applications in gene delivery and gene silencing

  2016cites this paper
• Principles of nanoparticle formation by flash nanoprecipitation

  2016cites this paper
• Titrating haemophilia B phenotypes using siRNA strategy: evidence that antithrombotic activity is separated from bleeding liability

  2015cites this paper
• siRNA-lipid nanoparticles with long-term storage stability facilitate potent gene-silencing in vivo.

  2015cites this paper
• Peptide nanofiber complexes with siRNA for deep brain gene silencing by stereotactic neurosurgery.

  2015cites this paper
• Bridging small interfering RNA with giant therapeutic outcomes using nanometric liposomes.

  2015cites this paper
• Proof-of-concept Studies for siRNA-mediated Gene Silencing for Coagulation Factors in Rat and Rabbit

  2015cites this paper
• Development of Lipoprotein(a) siRNAs for Mechanism of Action Studies in Non-Human Primate Models of Atherosclerosis

  2015cites this paper
• Cationic liposome-nucleic acid complexes for gene delivery and gene silencing.

  2014cites this paper
• Discovery of siRNA lipid nanoparticles to transfect suspension leukemia cells and provide in vivo delivery capability.

  2014cites this paper
• A Single Dose of EGLN1 siRNA Yields Increased Erythropoiesis in Nonhuman Primates

  2014cites this paper
• siRNA-Mediated Knockdown of P450 Oxidoreductase in Rats: A Tool to Reduce Metabolism by CYPs and Increase Exposure of High Clearance Compounds

  2014cites this paper
• Stabilization of Ostwald ripening in low molecular weight amino lipid nanoparticles for systemic delivery of siRNA therapeutics.

  2014cites this paper
• Perspectives and Challenges of Cell-Penetrating Peptides in Effective siRNA Delivery

  2014cites this paper
• Quantitation of physiological and biochemical barriers to siRNA liver delivery via lipid nanoparticle platform.

  2014cites this paper
• Lipid-based nanoparticles in the systemic delivery of siRNA.

  2014cites this paper
• Mechanism of macromolecular structure evolution in self-assembled lipid nanoparticles for siRNA delivery.

  2014cites this paper
• Microprecision delivery of oligonucleotides in a 3D tissue model and its characterization using optical imaging.

  2013cites this paper
• Technologies for Investigating the Physiological Barriers to Efficient Lipid Nanoparticle–siRNA Delivery

  2013cites this paper
• Delivery materials for siRNA therapeutics.

  2013cites this paper
• Natural or synthetic nucleic acids encapsulated in a closed cavity of amphiphiles

  2013cites this paper